| Association of uric acid with change in kidney function in healthy normotensive individuals G Bellomo, S Venanzi, C Verdura, P Saronio, A Esposito, M Timio American Journal of Kidney Diseases 56 (2), 264-272, 2010 | 337 | 2010 |
| Prognostic value of 24-hour blood pressure in pregnancy G Bellomo, PL Narducci, F Rondoni, G Pastorelli, G Stangoni, G Angeli, ... Jama 282 (15), 1447-1452, 1999 | 225 | 1999 |
| Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias L Parnetti, D Chiasserini, G Bellomo, D Giannandrea, C De Carlo, ... Movement Disorders 26 (8), 1428-1435, 2011 | 197 | 2011 |
| Prognostic significance of serum uric acid in women with gestational hypertension G Bellomo, S Venanzi, P Saronio, C Verdura, PL Narducci Hypertension 58 (4), 704-708, 2011 | 139 | 2011 |
| Performance of Aβ 1-40, Aβ 1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment L Parnetti, D Chiasserini, P Eusebi, D Giannandrea, G Bellomo, ... Journal of Alzheimer's Disease 29 (1), 229-238, 2012 | 134 | 2012 |
| The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction G Bellomo, S Paciotti, L Gatticchi, L Parnetti Movement Disorders 35 (1), 34-44, 2020 | 90 | 2020 |
| Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease G Bellomo, L Santambrogio, M Fiacconi, AM Scarponi, G Ciuffetti Journal of neurology 238, 19-22, 1991 | 90 | 1991 |
| Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies L Parnetti, C Balducci, L Pierguidi, C De Carlo, M Peducci, C D'Amore, ... Neurobiology of disease 34 (3), 484-486, 2009 | 80 | 2009 |
| Are we ready for detecting α-synuclein prone to aggregation in patients? The case of “protein-misfolding cyclic amplification” and “real-time quaking-induced conversion” as … S Paciotti, G Bellomo, L Gatticchi, L Parnetti Frontiers in neurology 9, 376477, 2018 | 79 | 2018 |
| Uric acid and chronic kidney disease: a time to act? G Bellomo World journal of nephrology 2 (2), 17, 2013 | 65 | 2013 |
| Inflammation, infection and cardiovascular events in chronic hemodialysis patients: a prospective study. G Bellomo, G Lippi, P Saronio, G Reboldi, C Verdura, F Timio, M Timio Journal of nephrology 16 (2), 245-251, 2003 | 54 | 2003 |
| CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment L Gaetani, FP Paoletti, G Bellomo, A Mancini, S Simoni, M Di Filippo, ... Trends in Pharmacological Sciences 41 (12), 1023-1037, 2020 | 53 | 2020 |
| α-Synuclein seed amplification assays for diagnosing synucleinopathies: the way forward G Bellomo, CMG De Luca, FP Paoletti, L Gaetani, F Moda, L Parnetti Neurology 99 (5), 195-205, 2022 | 52 | 2022 |
| Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid J Gobom, L Parnetti, P Rosa-Neto, M Vyhnalek, S Gauthier, S Cataldi, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (2), 207-219, 2022 | 51 | 2022 |
| Parkinson's and Lewy body dementia CSF biomarkers L Parnetti, S Paciotti, L Farotti, G Bellomo, FN Sepe, P Eusebi Clinica Chimica Acta 495, 318-325, 2019 | 50 | 2019 |
| The effect of psychological intervention on thirst and interdialytic weight gain in patients on chronic hemodialysis: a randomized controlled trial G Bellomo, P Coccetta, F Pasticci, D Rossi, A Selvi Journal of Renal Nutrition 25 (5), 426-432, 2015 | 47 | 2015 |
| Alpha and beta synucleins: from pathophysiology to clinical application as biomarkers L Barba, F Paolini Paoletti, G Bellomo, L Gaetani, S Halbgebauer, P Oeckl, ... Movement Disorders 37 (4), 669-683, 2022 | 41 | 2022 |
| Neuroinflammation and Alzheimer’s disease: a machine learning approach to CSF proteomics L Gaetani, G Bellomo, L Parnetti, K Blennow, H Zetterberg, M Di Filippo Cells 10 (8), 1930, 2021 | 41 | 2021 |
| Serum uric acid and pre-eclampsia: an update G Bellomo Expert review of cardiovascular therapy 10 (6), 701-705, 2012 | 39 | 2012 |
| An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity? M Sciaccaluga, A Megaro, G Bellomo, G Ruffolo, M Romoli, E Palma, ... International Journal of Molecular Sciences 22 (11), 5991, 2021 | 37 | 2021 |
